Medical Journals

Chemical Genetics Approach to Identify Peptide Ligands That Selectively Stimulate Dapk-1 Kinase Activity.

Authors:
  • Fraser Jennifer A
  • Hupp Ted R

From: Cancer Research UK p53 Signal Transduction Group, University of Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XRUK.

Biochemistry

  • Publish Date: Mar 2007
  • ISSN: 0006-2960
  • Volume: 46
  • Issue: 10
  • Pages: 2655-73
  • Medium: Print
  • Language: English
  • Citation (JAMA): Fraser Jennifer A, Hupp Ted R, et al. Chemical Genetics Approach to Identify Peptide Ligands That Selectively Stimulate Dapk-1 Kinase Activity.. Biochemistry Mar 2007;46:2655-73

Abstract

Dissection of signal transduction pathways has been advanced by classic genetic approaches including targeted gene deletion and siRNA-based inhibition of gene product synthesis. Chemical genetics is a biochemical approach to develop small peptide-mimetic ligands to alter, post-translationally, how an enzyme functions. DAPK-1 was used as a model enzyme to develop selective peptide ligands that modulate its specific activity. The tumor modifier p21 has the most highly conserved elements of a DAPK consensus substrate, including a basic core followed by a hydrophobic core. Therefore, the p21 protein was synthesized in overlapping fragments to acquire a panel of peptide ligands for testing in DAPK binding and phosphorylation assays. Three distinct p21 derived peptide fragments were found to bind to DAPK; however, these had no stimulatory effect on its activity toward in vivo substrates, p21 and MLC. The p21 peptide ligands did, however, strikingly stimulate DAPK activity toward p53, a substrate that shows conservation in the hydrophobic part of its DAPK-1 consensus site. DAPK-1 stimulatory peptides attenuate tryptic cleavage of DAPK-1, suggesting that ligand binding can alter DAPK-1 conformation and lock the enzyme onto its substrate. We, therefore, generated an artificial p53, containing arginine residues N-terminal to the phospho-acceptor site, creating a better DAPK-1 peptide consensus and demonstrated that the Km for p531-66[ET — >RR] and ATP is elevated. The full-length p53E17T18 — >R17R18 also functioned as a better Ser20 kinase substrate in vivo. These data suggest that DAPK-1 binding ligands can be generated to elevate its specific activity toward weak substrates and provide an approach to develop genetic assays to alter DAPK-1-specific activity in vivo.

Mesh Headings (Keywords): Animals, Apoptosis Regulatory Proteins, Calcium-Calmodulin-Dependent Protein Kinases, Cells, Cultured, Enzyme Activation, Humans, Insects, Ligands, Molecular Sequence Data, Peptides, Sequence Homology, Amino Acid


Check for Full Text / PubMed Unique Identifier (PMID): 17297916


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.